Related references
Note: Only part of the references are listed.The changing risk of Plasmodium falciparum malaria infection in Africa: 2000-10: a spatial and temporal analysis of transmission intensity
Abdisalan M. Noor et al.
LANCET (2014)
Fighting drug-resistant Plasmodium falciparum: the challenge of artemisinin resistance
C. Wongsrichanalai et al.
CLINICAL MICROBIOLOGY AND INFECTION (2013)
Global malaria mortality between 1980 and 2010: a systematic analysis
Christopher J. L. Murray et al.
LANCET (2012)
From Millennium Development Goals to Sustainable Development Goals
Jeffrey D. Sachs
LANCET (2012)
Some Lessons for the Future from the Global Malaria Eradication Programme (1955-1969)
Jose A. Najera et al.
PLOS MEDICINE (2011)
Malaria in Africa: progress and prospects in the decade since the Abuja Declaration
Robert W. Snow et al.
LANCET (2010)
Vivax Malaria: A Major Cause of Morbidity in Early Infancy
Jeanne R. Poespoprodjo et al.
CLINICAL INFECTIOUS DISEASES (2009)
Changes in malaria indices between 1999 and 2007 in The Gambia: a retrospective analysis
Serign J. Ceesay et al.
LANCET (2008)
Effect of a fall in malaria transmission on morbidity and mortality in Kilifi, Kenya
Wendy P. O'Meara et al.
LANCET (2008)
Efficacy of RTS,S/AS01E Vaccine against Malaria in Children 5 to 17 Months of Age
Philip Bejon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Declining artesunate-mefloquine efficacy against falciparum malaria on the Cambodia-Thailand border
Chansuda Wongsrichanalai et al.
EMERGING INFECTIOUS DISEASES (2008)
Efficacy of the RTS,S/AS02A vaccine against Plasmodium falciparum infection and disease in young African children:: randomised controlled trial
PL Alonso et al.
LANCET (2004)
The economic and social burden of malaria
J Sachs et al.
NATURE (2002)